🟢 Inovio Pharmaceuticals is trading 5.81% up today amid broader biotech gains

Inovio Pharmaceuticals is trading at $1.36, up 5.81%, with the move appearing mainly sector-driven amid improved biotechnology sentiment.

• No new company-specific announcement dated August 26, 2026, was identified.
• The latest material update remains the August 12 earnings release, which reported advancing FDA review for INO-3107 toward its October 30, 2026, PDUFA date.
• Biotech ETF XBI rose 2.06% during regular trading.